Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

37.20
Delayed Data
As of 4:00pm ET
 -0.45 / -1.20%
Today’s Change
26.95
Today|||52-Week Range
51.10
-18.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues70.9M67.3M79.1M74.6M
 
 
 
 
 
Cost of Goods Sold20.1M14.9M17.6M20.1M
 
 
 
 
 
Depreciation And Amortization3.7M3.4M3.7M2.8M
 
 
 
 
 
 
Operating ExpensesGross Income47.1M49.1M57.8M51.7M
 
 
 
 
 
General Expenses58.4M52.4M49.2M58.6M
 
 
 
 
 
Research And Development18.9M11.8M10.0M14.4M
 
 
 
 
 
Total Operating Expenses82.2M70.6M70.5M81.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.3M-3.3M8.6M-6.8M
 
 
 
 
 
Extraordinary Charge-4.5M-260.0K-113.0K-90.0K
 
 
 
 
 
Interest Expense On Debt5.4M5.4M5.5M5.6M
 
 
 
 
 
Other Expenses80.0K79.0K-2.0K75.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.7M-7.6M4.6M-10.6M
 
 
 
 
 
Income Taxes-30.0K-45.0K-35.0K-35.0K
 
 
 
 
 
Net Income-19.7M-7.6M4.6M-10.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS40.2M40.5M40.6M40.7M
 
 
 
 
 
Shares To Calculate EPS Diluted40.2M40.5M41.6M40.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.49-$0.19$0.11-$0.26
 
 
 
 
 
EPS Diluted-$0.49-$0.19$0.11-$0.26